Načítá se...
Denosumab reduces early migration in total knee replacement: A randomized controlled trial involving 50 patients
BACKGROUND AND PURPOSE: Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Migration of implants as measured by radiostereometric analysis (RSA) can predict future loosening. This migration is associated with bone resorption. Denosumab is a human monoclonal antibody...
Uloženo v:
| Vydáno v: | Acta Orthop |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5434591/ https://ncbi.nlm.nih.gov/pubmed/28287004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17453674.2017.1300746 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|